Skip to content
TrialScanner

NCT03761017

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Phase 1CompletedMGNXLead

Registry record

Lead sponsor
MacroGenics
Conditions
Squamous Cell Non Small Cell Lung Cancer; Prostate Cancer Metastatic; Cutaneous Melanoma; Colorectal Cancer; Advanced Cancer
Primary completion
Aug 29, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03761017 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03761017: MGD019 DART® Protein in... | TrialScanner